LAUREANO SIMON, Oncomatryx CEO, declares war on tumor microenvironment.

“We envision a new era where cancer in general and invasive tumors in particular will be beaten with orchestrated combinations of precision drugs that target the epitelial tumor cells, to block tumor growth and drugs that target the tumor microenvironment, to block tumor invasion, angiogenesis, metastasis, immunosupression and drug resistance. I declare war on cancer stroma.”